DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bevacizumab
Bevacizumab
Response to Trastuzumab, Erlotinib, and Bevacizumab, Alone and In
Bevacizumab) Injection, for Intravenous Use Persistent, Recurrent, Or Metastatic Cervical Cancer (2.6) Initial U.S
Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities
Cardiotoxicity Associated with Targeted Cancer Therapies (Review)
Bevacizumab (Avastin) in Combination with Trastuzumab and Docetaxel for Metastatic HER2 Positive Breast Cancer – First Line
Effectiveness and Costs Associated to Adding Cetuximab Or Bevacizumab
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Amgen and Allergan's MVASI™ (Bevacizumab-Awwb) and KANJINTI™ (Trastuzumab-Anns) Now Available in the United States
Section 21 Ophthalmological Preparations Bevacizumab
PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use ------CONTRAINDICATIONS------VECTIBIX Safely and Effectively
Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient with Non-Small Cell Lung Cancer
Vectibix, INN-Panitumumab
Trastuzumab Deruxtecan for the Treatment of HER2-Positive Advanced Gastric Cancer: a Clinical… 569
Hypertension Secondary to Anti-Angiogenic Therapy: Experience with Bevacizumab
Ep 3321281 A1
Expanding Frontiers, Transforming Cancer Treatment
Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Versus Bevacizumab in Metastatic Colorectal Cancer: a Systematic Review and Meta-Analysis
Top View
Zydus Launches Ujvira (Trastuzumab Emtansine), a Breakthrough in Breast Cancer Treatment
NCCN Guidelines for Patients Metastatic Breast Cancer
MAHA) in Patients Treated with Avastin® (Bevacizumab) and Sunitinib Malate
125427Orig1s000
Avastin, INN-Bevacizumab
Antitumor Activity of Capecitabine and Bevacizumab Combination in a Human Estrogen Receptor-Negative Breast Adenocarcinoma Xenograft Model
(INN) for Biological and Biotechnological Substances
Phase II Trial of FOLFOX6, Bevacizumab, and Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Gastric Cancers
Correlation Between the Qualification for Bevacizumab Use and The
Bevacizumab, Sunitinib: Osteonecrosis of the Jaw Venous Sclerosants
Real-World Effectiveness of Post-Trastuzumab Emtansine
Evolution of Escherichia Coli Expression System in Producing Antibody Recombinant Fragments
Vectibix (Panitumumab) Is a Recombinant, Human Igg2 Kappa Monoclonal Antibody That Binds Specifically to the Human Epidermal Growth Factor Receptor (EGFR)
SUTENT (Sunitinib Malate)
DRUG NAME: Bevacizumab
Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: a Decision Analysis
An Overview of the Current Status of Engineered Therapeutic Monoclonal Antibodies